M.M. Dillon

M.M. Dillon & Co. believes that growth enterprises including public companies, privately owned businesses and entrepreneurs in the middle market require personalized, high-quality investment banking expertise. Most of the large Wall Street firms, including the bulge-bracket investment banks, depend on large clients and transactions to support high-cost infrastructures and cannot afford to invest the time and skilled professionals required to service the middle market. Middle-market boutique advisory firms, on the other hand, often lack the investment banking experience and the execution professionals required to guide their clients through complex situations and transactions - precisely the time when their clients need them most.

1 past transactions

Akonni Biosystems

Series D in 2017
Akonni Biosystems is a biotechnology company that develops and manufactures, genetic testing devices. Its devices are designed for complex infectious and human health diseases like Methicillin-resistant Staphylococcus aureus (MRSA), multi-drug-resistant tuberculosis (MDR-TB), and influenza sub-typing with oseltamivir-resistance detection. It was founded in 2003 and headquartered in Maryland, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.